Weisong Xu

机构：Nantong University, Affiliated Hospital of Nantong University · ORCID：0000-0002-9023-5887

发表论文 23 篇 · 总被引 461 次 · h-index 9

代表论文

• The biogenesis and secretion of exosomes and multivesicular bodies (MVBs): Intercellular shuttles and implications in human diseases (2022 · Genes & Diseases · 被引 260)
• Glycolysis in the tumor microenvironment: a driver of cancer progression and a promising therapeutic target (2024 · Frontiers in Cell and Developmental Biology · 被引 73)
• The AKR1B1 inhibitor epalrestat suppresses the progression of cervical cancer (2020 · Molecular Biology Reports · 被引 30)
• A nano silicon adjuvant enhances inactivated transmissible gastroenteritis vaccine through activation the Toll-like receptors and promotes humoral and cellular immune responses (2018 · Nanomedicine Nanotechnology Biology and Medicine · 被引 29)
• Identification of prognostic risk factors for pancreatic cancer using bioinformatics analysis (2020 · PeerJ · 被引 17)
• The telomere-to-telomere (T2T) genome of Peucedanum praeruptorum Dunn provides insights into the genome evolution and coumarin biosynthesis (2024 · GigaScience · 被引 15)